Americaine

Quick links to important sections

Americaine

Method of action: Anesthetic, Local, Local Anesthetic

Treatment option: Hemorrhoids, Colic

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Americaine

Quick Facts

Property Description
Active ingredient Benzocaine (Ethyl aminobenzoate)
Form Topical spray, Ointment, Suppository
Pharmacological class Local Anesthetic (Ester-type)
Common use Relief of localized pain and discomfort
Origin Synthetic organic compound

What Type of Medicine is Americaine?

Americaine is a topical preparation that relies on the active ingredient Benzocaine, which is formally classified as an ester-type local anesthetic. The medicine is a synthetic organic compound derived from 4-aminobenzoic acid, and its pharmacological action is clinically recognized for reducing discomfort. Benzocaine functions by intercepting the electrical signals in sensory nerves at the application site, creating a temporary sensory block. The classification as a local anesthetic positions Americaine as a solution focused exclusively on localized sensation relief.


Composition and Available Forms

The primary component is Benzocaine (Ethyl aminobenzoate), which is formulated into various dosage form(s) for topical administration, including the topical spray (aerosol), ointment, and suppository. This variety ensures flexibility in targeting different anatomical sites. These preparations utilize specific vehicle components to aid delivery; for instance, the spray employs propellants and alcohol, while the ointment uses a thicker petrolatum base. Benzocaine is used to reduce pain and discomfort caused by minor skin irritations, consistent with its single-active-ingredient formulation and specialized delivery.


Americaine's General Purpose

The general purpose of Americaine is to provide immediate, temporary relief from acute localized pain and topical discomfort through surface anesthesia. This effect is achieved exclusively through a localized sensory block at the application site. This focused mechanism ensures that the medicine is strictly limited to managing superficial sensations, such as minor pain, itching, and burning, without affecting deeper tissues or interfering with the central nervous system.

Regulatory References

  1. https://www.ncbi.nlm.nih.gov/books/NBK539823/

What side effects are possible with Americaine?

Possible Side Effects and Safety Information

Americaine's active ingredient, Benzocaine, has an officially documented safety profile characterized by a range of localized effects and one serious, rare systemic risk, as outlined in regulatory labeling.


Adverse Reaction Scope

Component Description
Key Adverse Reactions Localized skin reactions/hypersensitivity and a rare systemic blood disorder.
System-Organ Classes Blood and Lymphatic System Disorders (Methemoglobinemia); Skin and Subcutaneous Tissue Disorders (e.g., burning, stinging, rash).
Frequency Classification The serious reaction, Methemoglobinemia, is classified as rare. Local reactions are generally the most frequent documented effects.

Clinically Significant and Serious Reactions

The most serious reaction documented in regulatory safety information is Methemoglobinemia, a potentially fatal blood disorder where oxygen saturation is reduced. This reaction is classified under Blood and Lymphatic System Disorders. Symptoms listed in official documents include pale, gray, or blue skin/lips/nail beds, headache, rapid heart rate, and shortness of breath. The onset of these symptoms can be rapid, appearing within minutes to one or two hours after use, and may occur with initial or subsequent exposure.


Regulatory Safety Restrictions

Safety documentation includes specific constraints for use. The medicine is contraindicated in infants and children younger than 2 years due to a heightened risk of Methemoglobinemia. Elderly patients and individuals with pre-existing heart disease, breathing problems, or hereditary metabolic disorders are also considered to be at greater risk for complications. Regulatory labeling further advises avoiding use on large areas of the body or on skin that is seriously damaged and notes that Benzocaine inhibits the actions of sulphonamides (Sulfa drugs).

Overdose and Emergency Response

The documented overdose profile for Americaine (Benzocaine) is defined by the risk of Methemoglobinemia, a rare but serious blood condition. This hematologic event reduces the capacity of the blood to carry oxygen and is classified in regulatory documents as a potentially fatal adverse effect, emphasizing the need for immediate response.

Category Documented Clinical Manifestation
Systemic Signs Pale, gray, or blue-colored skin, lips, or nail beds (cyanosis).
Acute Symptoms Shortness of breath, rapid heart rate (tachycardia), headache, lightheadedness, confusion, and fatigue.

Immediate medical attention must be sought if any of these signs are observed, as symptoms are documented to appear rapidly, typically within minutes to two hours following product use. This mandatory emergency action is based on the potential for severe hypoxia. The risk of this serious reaction is officially documented as higher in specific populations, notably in infants and children younger than 2 years, as well as in patients with underlying heart or breathing problems. Professional management cited in regulatory documents involves careful monitoring, supportive care, and the administration of the specific antidote, Methylene Blue.

Therapeutic Uses of Americaine

What Americaine Treats: Main Uses and Benefits

Americaine is a topical preparation that may be used for supportive symptom management across domains involving acute, superficial discomfort. The medicine is commonly applied in clinical settings that involve acute or unstable symptom patterns where short-term symptomatic assistance is needed.

The medication's primary therapeutic role is to provide targeted symptomatic relief for localized discomfort. This includes symptoms arising from common conditions such as minor cuts, scrapes, insect stings, non-severe sunburn, painful canker sores, irritation of the mouth lining, and the pain and itching associated with hemorrhoids. The preparation may be applied when symptoms intensify and supportive relief is needed, or during phases where patients experience heightened distress.

“The medication is relevant in contexts marked by increased discomfort or tension, helping to manage symptoms that interfere with daily comfort.”

This approach contributes to easing the overall symptom burden, and it supports the patient during difficult episodes by generally providing rapid, temporary numbing at the affected site.


Quick Fact: Relief for Acute Surface Discomfort
The primary intent is focused on: Localized sensation relief
Symptom areas addressed: Pain, burning, stinging, and itching (pruritus)
Situations where use is common: Minor injuries, oral lesions, and anorectal irritation

Eligibility and Restrictions for Use

Who Can and Cannot Use Americaine?

The official eligibility profile for Americaine (Benzocaine) is defined by regulatory mandates that specify minimum age, hypersensitivity status, and pre-existing health conditions.


Populations and Eligibility Status

Classification Status According to Regulatory Labeling
Allowed Populations Adults and children 2 years of age and older are eligible for general over-the-counter (OTC) use.
Absolute Contraindication Children younger than 2 years of age are strictly prohibited from using oral OTC Benzocaine products.
Hypersensitivity Contraindicated in patients with a known allergy to Benzocaine, other ester-type local anesthetics, or PABA.

Restricted and Conditional Use

  • Higher-Risk Groups: Use is restricted for specific populations identified as being at greater risk for developing complications, including older adults (geriatrics) and patients who smoke.
  • Comorbidity Restrictions: Individuals with pre-existing conditions affecting the blood, such as G6PD deficiency or other inborn metabolic defects, as well as those with respiratory (e.g., asthma) or cardiac disease, are designated as a high-risk population.
  • Pregnancy Status: Benzocaine is classified as FDA Pregnancy Category C; use is permitted only when the potential benefit outweighs the potential risk. During lactation, use is conditional, and regulatory guidance advises avoiding application to the breast or nipple area.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Americaine (benzocaine) can interact with other products, primarily by contributing to additive toxic effects as documented in regulatory information. The most significant interaction concern is the increased risk of a serious condition called methemoglobinemia.


Documented Interaction Categories

Interaction Type Interacting Product Category
Additive Pharmacodynamic Risk Other methemoglobinemia-inducing agents, including other local anesthetics (e.g., lidocaine, prilocaine) and oxidizing agents (e.g., dapsone, nitrates).
Additive Pharmacodynamic Risk Central Nervous System (CNS) depressants.
Non-Drug Additive Risk Products and substances containing nitrites and nitrates, such as certain foods and water sources.

Clinical Constraints and Population Notes

Co-administration with other methemoglobinemia-inducing agents is constrained by regulatory authorities due to the serious additive risk. The official profile also notes that the risk and severity of this interaction are heightened in specific patient populations, including those with predisposing conditions such as G-6-PD deficiency or underlying respiratory or cardiac disease. Older adults are also identified as being at greater risk. The profile also lists substances that may theoretically increase or decrease benzocaine’s concentration in the bloodstream.

Mechanism of Action

The physiological mechanism of Americaine is defined by its sole active component, Benzocaine, which functions as a non-competitive inhibitor of Voltage-Gated Sodium Channels (VGSCs). Being a highly lipophilic and neutral molecule, Benzocaine rapidly diffuses across the lipid bilayer of sensory neuronal membranes. Once inside, it gains access to the inner cavity of the VGSC pore.

This molecular blockade physically prevents the necessary, rapid influx of sodium ions ( Na^+) into the neuron. Consequently, the nerve membrane is unable to undergo the required depolarization, leading to the functional arrest of the Action Potential (AP), the electrical impulse that transmits information. This cascade results in the temporary and reversible stabilization of the nerve membrane and the absence of afferent signal transmission at the site of application. The mechanism is strictly peripheral and is limited by tissue barriers, preventing action on signals from deep tissue structures.

Dosage and Administration Information

How Americaine Is Used: Administration Guidelines

The administration of Americaine, which contains benzocaine, is strictly defined as topical for external use on the skin, external anorectal areas, and oral mucosal tissues. This route supports the product’s use as a localized application for acute discomfort. Dosing frequency is regulated and must not be exceeded: for general topical or skin application, the product is applied not more than three to four times daily.

Specific products, such as the external anorectal ointment, adhere to a regimen permitting application up to six times daily. The ointment may be applied with specific reference to activity, such as after each bowel movement. Before using the aerosol spray, the container must be shaken well. If a scheduled dose is missed, it should be applied as soon as possible, but the missed dose is skipped if it is near the time for the next scheduled application.

Use of this medication is restricted to adults and children two years of age and older, and instructions prohibit use in children under two years of age. Children under the age of twelve require adult supervision during product use. The medication is intended for short-term, intermittent use, and application must be discontinued if the treated condition does not show improvement within seven consecutive days.

As a crucial procedural constraint, the product is for external use only, and the label explicitly instructs against introducing the anorectal ointment into the rectum using fingers or any mechanical applicator. The aerosol spray is a flammable mixture and must be kept away from fire or flame.

Recent Clinical Evidence

Research evidence / Overview of studies


Overview of Clinical Trials

Research has investigated the potential for a change in the quality of life and examined the effect on anxiety in the studied populations. Studies evaluated whether there was a reduction in symptoms for individuals with moderate to severe conditions. Evidence remains limited regarding long-term, multi-year outcomes, and it is not yet clear whether the effects differ substantially across all demographic groups.

Preclinical research has explored the hypothesized pathway for the study drug.


Key Efficacy Findings

This is a compound that has been investigated in trials for the studied condition. Key findings from placebo-controlled trials include:

  • Symptom Resolution: Studies examined the speed of symptom resolution in acute episodes and compared the findings to older treatments.
  • Response Rate: Trials measured the percentage of individuals who met predefined criteria for a clinically meaningful outcome over a 12-week period.
  • Recurrence: Research evaluated the rate of symptom return following the cessation of the study treatment.

Safety and Tolerability Profile

Studies evaluated the occurrence of events such as temporary mild headaches and fatigue. These events were generally reported as resolving without intervention.

  • Long-Term Use: Long-term safety profiles were evaluated in studies lasting up to six months.
  • Dependency Potential: Research investigated the potential for dependency or habit-forming behavior.
  • Drug-Drug Interactions: Studies evaluated whether the combination of compounds A and B affected absorption and clearance of other commonly used medications.

Dosage Used in Studies

Studies investigated a dosage range starting at 5 mg, with a maximum dose of 10 mg, based on trial protocols. Dosages exceeding 15 mg per day were not investigated in the primary efficacy trials.

Frequently Asked Questions (FAQ)

Common questions about Americaine (FAQ)

Q: How quickly does Americaine start working after applying it?

A: Americaine’s active ingredient is classified as a local anesthetic, which acts by temporarily blocking nerve signals at the application site. Official information indicates the effects are typically designed to begin rapidly, often within a few minutes of application.

Q: How long do the effects of Americaine usually last?

A: Regulatory documents describe Americaine as providing temporary relief from pain and discomfort. Official dosing frequency guidelines, such as applying no more than three or four times daily, suggest the effect is temporary, lasting a limited duration before reapplication is permitted.

Q: Does using too much Americaine cause more side effects?

A: Official warnings state that using the active ingredient too frequently, exceeding the recommended dosage, applying it over large areas, or using it for prolonged periods can increase risk. Specifically, this misuse is associated with an increased chance of rare but serious systemic side effects, including the blood disorder, methemoglobinemia.

Q: Is it true that Americaine can be absorbed into the bloodstream?

A: Yes, regulatory warnings confirm that the active ingredient in Americaine can be absorbed into the bloodstream from the application site. This systemic absorption is the pathway for the rare, serious side effect known as methemoglobinemia, which is why official labeling emphasizes strict adherence to usage guidelines.

Q: Is it normal to feel a tingling sensation after applying Americaine?

A: Official documentation on adverse reactions lists localized skin effects such as burning, stinging, rash, and itching as documented reactions. While 'tingling' may not be explicitly listed, these sensations are consistent with the general nerve block mechanism and the drug's known localized adverse reaction profile.

Q: Can I use Americaine on open cuts or wounds?

A: Official warnings advise caution and recommend against using Americaine on large areas of the body or on seriously damaged skin. Specific instructions for certain product forms also advise against use on open wounds, as this is associated with a greater chance of increased absorption of the active ingredient.

Q: What happens if you use Americaine for longer than the package suggests?

A: Regulatory information advises that application must be discontinued if the treated condition does not show improvement within seven consecutive days. Using the product for longer than this recommended short-term period is associated with potential risks stemming from increased absorption into the bloodstream over time.

Q: Are there long-term side effects from using Americaine frequently?

A: The product is authorized for short-term, intermittent use only. While some studies have evaluated safety profiles up to six months, regulatory guidance suggests caution, and use beyond the documented short-term period (seven days) should be avoided due to potential risks associated with prolonged absorption.

Q: Is Americaine the same thing as lidocaine?

A: No, the active ingredient in Americaine is benzocaine, which is classified as an ester-type local anesthetic. Lidocaine is a separate compound, classified as an amide-type local anesthetic. Official documents also note that combining the two may increase the risk of methemoglobinemia, indicating they are distinct agents.

Q: Why do people use Americaine for sunburns if it's not specifically for that?

A: Official indications for use actually include the temporary relief of pain and itching caused by minor skin irritations. This specifically includes minor burns, such as sunburn, meaning the use for this condition is one of the authorized indications found in regulatory documents.

Q: What happens if you accidentally swallow a small amount of Americaine?

A: Official warnings clarify that this product is for external use only. Ingestion, particularly in young children, is associated with the risk of serious systemic effects. Regulatory agencies warn that swallowing the product can cause the potentially fatal blood disorder, methemoglobinemia.

Q: Can I use Americaine for an allergic reaction or hives?

A: The product is officially indicated for temporary relief of pain and itching caused by minor skin irritations. However, official safety documents list localized allergic reactions (such as hives, rash, or itching) as possible side effects of Americaine itself.

Q: Does Americaine contain steroids?

A: No, the official composition listed in regulatory documents specifies the sole active ingredient is benzocaine, which is classified as a local anesthetic. Steroid compounds are not listed as active components in the product formulation.

Q: Why do I sometimes see Americaine mentioned for hemorrhoid relief?

A: Specific Americaine formulations, such as the anorectal ointment, are indicated in official labeling for temporary relief of pain, discomfort, soreness, or burning associated with conditions like hemorrhoids and other anorectal disorders.

Q: What makes Americaine different from a topical analgesic like menthol?

A: Americaine’s active ingredient, benzocaine, is a local anesthetic that works by temporarily blocking nerve signals to prevent pain transmission. In contrast, substances like menthol are typically classified as counterirritants, which are thought to provide pain relief through a different mechanism, such as a cooling or warming sensation.

Q: Can I apply heat or a heating pad after using Americaine?

A: Official warnings advise against covering the application area with a bandage or occlusive dressing. Furthermore, the spray formulation has warnings regarding heat and fire. Regulatory constraints suggest caution, as any co-application of heat may increase the systemic absorption of the product.

Q: Does Americaine have different brand names in other countries?

A: Yes, the active ingredient, benzocaine, is a common compound in medical products across the globe. Consequently, it is sold under various different local brand names and formulations in international markets, consistent with its function as a local anesthetic.

Q: Does the evidence for Americaine come from clinical trials?

A: Yes, regulatory approvals for Americaine and its supporting documentation are based on evidence, which includes data gathered from clinical trials and other research studies that investigate the drug’s intended effects and safety profile.

Q: Can Americaine be used on the face?

A: Americaine is intended for external use on the skin. Regulatory constraints advise caution by warning against contact with the eyes, and some forms are for oral mucosal tissues. Official labeling emphasizes safe, external application but does not define application on the face as a standard, authorized use.

Q: Is Americaine effective for relieving itching as well as pain?

A: Yes, official indications for Americaine include the temporary relief of pain and localized discomfort, which specifically covers itching caused by minor skin irritations and other conditions for which it is authorized.

How should Americaine be stored and disposed of?

How to Store and Dispose of Americaine?

Americaine topical products must be stored at room temperature. The ointment formulation typically requires temperatures between 15 C and 30 C (59 F and 86 F).

Storage Requirements

Condition Requirement
Temperature Store at room temperature; do not expose the spray above 49 C (120 F).
Aerosol Warning Container is pressurized; do not puncture, incinerate, or use near fire.
Child Safety Keep out of the sight and reach of children.

Disposal

The preferred method for discarding unused or expired product is a drug take-back program. If unavailable, the medicine should be mixed with an unappealing substance (like used coffee grounds) and sealed in a bag for household trash disposal. Local facilities should be consulted for the specific disposal of pressurized aerosol cans.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Americaine found in:

A-Z Index: